Galmed Pharmaceuticals Ltd. buy Roth Mkm
Start price
20.10.23
/
50%
€0.39
Target price
20.10.24
€70.85
Performance (%)
-12.95%
Price
04.06.24
€0.34
Summary
This prediction is currently active. The price of Galmed Pharmaceuticals Ltd. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.95%. This prediction currently runs until 20.10.24. The prediction end date can be changed by Roth_Mkm at any time. Roth_Mkm has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Galmed Pharmaceuticals Ltd. | 0.000% | 0.000% |
iShares Core DAX® | 0.597% | 3.083% |
iShares Nasdaq 100 | 0.899% | 5.338% |
iShares Nikkei 225® | 1.775% | -1.206% |
iShares S&P 500 | 0.990% | 3.500% |
Comments by Roth_Mkm for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $75.00 price target on the stock.
Ratings data for GMED provided by MarketBeat